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ARTICLE
Novofumigatonin biosynthesis involves a non-
heme iron-dependent endoperoxide isomerase for
orthoester formation
Yudai Matsuda 1,2,3, Tongxuan Bai2, Christopher B.W. Phippen1, Christina S. Nødvig1, Inge Kjærbølling1,
Tammi C. Vesth1, Mikael R. Andersen 1, Uffe H. Mortensen 1, Charlotte H. Gotfredsen 4,
Ikuro Abe 2 & Thomas O. Larsen 1
Novofumigatonin (1), isolated from the fungus Aspergillus novofumigatus, is a heavily oxy-
genated meroterpenoid containing a unique orthoester moiety. Despite the wide distribution
of orthoesters in nature and their biological importance, little is known about the biogenesis
of orthoesters. Here we show the elucidation of the biosynthetic pathway of 1 and the
identiﬁcation of key enzymes for the orthoester formation by a series of CRISPR-Cas9-based
gene-deletion experiments and in vivo and in vitro reconstitutions of the biosynthesis. The
novofumigatonin pathway involves endoperoxy compounds as key precursors for the
orthoester synthesis, in which the Fe(II)/α-ketoglutarate-dependent enzyme NvfI performs
the endoperoxidation. NvfE, the enzyme catalyzing the orthoester synthesis, is an Fe(II)-
dependent, but cosubstrate-free, endoperoxide isomerase, despite the fact that NvfE shares
sequence homology with the known Fe(II)/α-ketoglutarate-dependent dioxygenases. NvfE
thus belongs to a class of enzymes that gained an isomerase activity by losing the α-
ketoglutarate-binding ability.
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Orthoesters are functional groups in which three alkoxygroups are bound to a single carbon atom. Orthoestersare widely distributed in plant metabolites1, but are also
found in biologically important bacterial natural products, such
as the sodium channel blocker tetrodotoxin2 and the orthoso-
mycin antibiotics3. Despite their intriguing structures and bio-
logical activities, little is known about the molecular basis for
orthoester biogenesis. To the best of our knowledge, the Fe(II)/α-
ketoglutarate (αKG)-dependent dioxygenases involved in the
biosynthesis of orthosomycins are the only examples of
orthoester-producing enzymes known to date4.
Novofumigatonin (1) is a fungal meroterpenoid discovered in
Aspergillus novofumigatus IBT 16806 (CBS117520)5, and it pos-
sesses a congested skeleton with an unusual orthoester moiety. It
has been proposed that 1 is biosynthesized via asnovolin A (2),
which was also isolated from the same A. novofumigatus strain
(Fig. 1a)6. Asnovolin A (2) is in turn derived from the polyketide
precursor 3,5-dimethylorsellinic acid (DMOA, 3), which also
serves as the starting material for diverse fungal meroterpenoids7.
We recently identiﬁed a putative biosynthetic gene cluster for 1
(the nvf cluster; Fig. 1b, Supplementary Figs. 1, 2 and Supple-
mentary Table 1)8, but no biosynthetic study of 1 has been
reported. Therefore, the biosynthetic pathway of 1, including the
mechanism for the orthoester formation, has yet to be elucidated.
Here we show the complete biosynthetic pathway of novofu-
migatonin (1) and characterization of key enzymes for the
orthoester synthesis. We initially create a series of gene-deletion
strains of A. novofumigatus and isolated several metabolites,
which we incorporated into a model for the biosynthetic route of
1 (Fig. 2a). The proposed pathway is further validated by het-
erologous expression experiments using Aspergillus oryzae and by
in vitro enzymatic reactions with puriﬁed enzymes. In the course
of our study, we achieve the total biosynthesis of 1 in the het-
erologous host A. oryzae, strongly indicating that the nvf cluster
genes are sufﬁcient to produce 1. We reveal the involvement of
two key enzymes for the orthoester synthesis, namely NvfI and
NvfE, which are responsible for the endoperoxidation and
endoperoxide isomerization, respectively, to afford the orthoester.
Most importantly, NvfE is characterized to be a non-heme iron-
dependent endoperoxide isomerase despite its sequence similarity
to known Fe(II)/αKG-dependent dioxygenases.
Results
Creation of an A. novofumigatus mutant for gene deletion. To
characterize the functions of each gene in the nvf cluster, we ﬁrst
created a mutant strain of A. novofumigatus in which genetic
modiﬁcations can be readily performed (Supplementary Figs. 3,
4). To this end, the pyrG and ligD genes encoding an orotidine 5′-
phosphate decarboxylase9 and a DNA ligase were deactivated and
deleted, respectively, by means of the recently developed fungal
CRISPR-Cas9 system10. The pyrG gene serves as a selectable/
counter-selectable genetic marker, and the disruption of ligD
reportedly increases the gene-targeting efﬁciency due to non-
functional non-homologous end-joining11, which, in most cases,
enabled efﬁcient gene deletion without further usage of the
CRISPR-Cas9 system and thus minimized vector construction
efforts in the following experiments. With this mutant strain
(pyrG–, ligDΔ) in hand, we initially deleted the polyketide syn-
thase (PKS) gene nvfA (Protein ID in JGI database: 455569; see
Supplementary Table 1 for details), which is expected to be
responsible for the ﬁrst committed step in the novofumigatonin
biosynthesis. The deletion of nvfA completely abolished the
production of 1 as well as 2 (Fig. 2b, lanes i and ii), indicating the
involvement of the nvf cluster in the novofumigatonin pathway
and strongly supporting the view that 2 is a precursor of 1.
Early-stage biosynthesis of 1. Since the initial biosynthetic steps
of DMOA-derived meroterpenoids adopted similar pathways to
afford their ﬁrst cyclized intermediates7, four gene products, the
prenyltransferase NvfB, the methyltransferase NvfJ, the ﬂavin-
dependent monooxygenase (FMO) NvfK, and the terpene cyclase
NvfL, as well as the PKS NvfA, were expected to be required for
the formation of a tetracyclic compound, by analogy to the bio-
syntheses of austinol, terretonin, and andrastin A (Supplementary
Fig. 5)12–15. First, the involvement of NvfB in the biosyntheses
and its function as a DMOA farnesyltransferase were conﬁrmed
by the deletion of nvfB (Fig. 2b, lane iii) and heterologous
expression of nvfB with the known DMOA-synthase gene
andM16 in the Aspergillus oryzae NSAR1 strain17, which yielded
farnesyl-DMOA (4) (Fig. 2d, lane ii and Supplementary Fig. 6).
Rather than the expected early intermediate, the nvfJΔ strain
accumulated the tetracyclic molecule 5, which was named
asnovolin I (Fig. 2b, lane xi). This result surprisingly revealed
that NvfJ acts after the cyclization event and therefore differs
from the methyltransferases in the known DMOA-derived
pathways, which require the methyl esteriﬁcation of 4 for the
activity of the terpene cyclases7. Consistent with this observation,
the nvfKΔ and nvfLΔ mutants both yielded compounds 4 and 6
with a free carboxyl group, respectively (Fig. 2b, lanes xii and xiii).
Compound 6 has a diol moiety at the terminus of the farnesyl
group, which is likely to be a consequence of the hydrolysis of the
expected epoxide 7. Collectively, the early-stage biosynthesis is
proposed as follows. The PKS NvfA forms DMOA (3), followed
by the farnesylation by NvfB, the epoxidation by NvfK, and the
protonation-initiated cyclization of 7 by NvfL, to afford 8 via the
cationic intermediate 9 (Fig. 2a).
Mid-stage biosynthesis of 1. In addition to the above-mentioned
mutants, three more strains, nvfCΔ, nvfHΔ, and nvfMΔ, were
unable to produce both 1 and 2 (Fig. 2b, lanes iv, ix, and xiv), and
therefore these genes are likely to be engaged in the pathway to 2.
Among the three mutants, the nvfCΔ strain did not accumulate
any detectable unknown metabolites, and therefore the function
of nvfC was investigated using the A. oryzae heterologous
expression system; the transformant harboring andM, nvfB, nvfK,
nvfL, and nvfC yielded both 8 and chermesin D (10)18, while the
transformant lacking nvfC only produced the alcohol form 8
(Fig. 2d, lanes iii and iv and Supplementary Fig. 6), establishing
the function of NvfC as a 3-OH dehydrogenase of 8. Compound
8 was hereby designated as asnovolin H.
The nvfHΔ strain accumulated the product 11, which was
named asnovolin J. The structure of 11 is nearly identical to that
of 2, and only lacks the oxygen atom between C-3 and C-4, which
established the FMO NvfH as a Baeyer–Villiger monooxygenase
(BVMO). Another close analog of 2, 12, with a double bond
between C-5′ and C-6′, was obtained from the nvfMΔ strain and
designated as asnovolin K. This indicates that NvfM is an
enoylreductase that reduces this double bond. Taken together,
our results suggest that there are two pathways to synthesize 2
from 10. In one branch, 10 undergoes Baeyer–Villiger oxidation,
methylation, and enoyl reduction to form 5, 12, and 2 in this
order, while in the other branch, the methylation precedes the
Baeyer–Villiger oxidation and the enoyl reduction to give 13, 11,
and 2, respectively (Fig. 2a). Consistently, the introduction of the
above-mentioned eight genes into A. oryzae successfully yielded 2
(Fig. 2d, lane v and Supplementary Fig. 6). In this proposed
pathway, the methyl esteriﬁcation by NvfJ occurs just before the
NvfM-catalyzed reduction. Without the methylation, a β-keto
acid that spontaneously undergoes decarboxylation would be
generated upon the enoyl reduction. Thus, the methyl group
could serve as a protecting group of carboxylic acid, which
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explains the different timing of the methylation in the
biosyntheses of 1 and the other known DMOA-derived
meroterpenoids (Fig. 2a and Supplementary Fig. 5).
Late-stage biosynthesis of 1. Asnovolin A (2), but not 1, was
detected in extracts from ﬁve mutants, nvfDΔ, nvfEΔ, nvfFΔ,
nvfGΔ, and nvfIΔ (Fig. 2b, lanes v to viii and x), suggesting that all
ﬁve genes are involved in the synthesis of 1 from 2. Except for the
nvfIΔ mutant, all produced 2 in combination with another
compound. The mutants without nvfD and nvfE accumulated the
metabolites 14 and 15, respectively (Fig. 2b, lanes v and vi).
Compound 14 was also produced by the nvfDΔ, nvfEΔ, nvfFΔ,
nvfGΔ quadruple-mutant strain (Fig. 2b, lane xv), indicating that
14 is the product of NvfI. To facilitate the isolation of 14, we
created another mutant in which a non-ribosomal peptide syn-
thase gene named e-anaPS (Supplementary Fig. 7 and Supple-
mentary Table 2) was deleted, since the gene is involved in the
production of epi-aszonalenin C8,19 co-eluting with 14 (Fig. 2c).
Interpretation of the NMR spectra suggested that the structures of
14 and 15 contain an endoperoxide linkage between C-13 and C-
2′ (Supplementary Figs. 8, 9). To prove the existence of the
peroxide, we sought to reduce the peroxide by palladium-
catalyzed hydrogenolysis20. The reduction of 15 provided the
single product 16 (Fig. 3), and the spiro-lactone 16 must be
derived from 17 with two hydroxyl groups at C-13 and C-2′, thus
conﬁrming the presence of the peroxide at these positions in 15.
Unfortunately, our attempt to reduce 14 generated a complex
mixture of products, but considering that 14 is biosynthetically
related to 15, we concluded that 14 has the same peroxide linkage
as 15. The endoperoxides 14 and 15 were named fumigatonoids
A and B, respectively.
The nvfFΔ and nvfGΔ mutants produced metabolites that
appeared to be shunt products. Asnovolin G6 (18), obtained from
the nvfFΔ strain, possesses a six-membered spiro-lactone moiety,
which appears to be generated by the translactonization after the
occurrence of the hydroxyl group at C-13. Compound 19 isolated
from the nvfGΔ strain, named novofumigatonol, was almost
identical to 1, and only differed by the hydroxyl group at C-5′.
Since it is unlikely that 18 and 19 serve as the direct precursors of
1, these compounds are likely synthesized in diverged pathways
from that for 1, as discussed later.
Taken together, our results indicate that the late-stage
biosynthesis of novofumigatonin (1) is initiated by the oxidation
of 2 to 14 by NvfI (Fig. 2a), which exhibits sequence similarity
with Fe(II)/αKG-dependent dioxygenases. The endoperoxide 14
would then be accepted by NvfD for the subsequent transforma-
tions. Since the methyl ester group present in 14 is missing in the
metabolites obtained from the nvfEΔ, nvfFΔ, and nvfGΔ strains,
NvfD is apparently involved in the lactonization process. To allow
lactonization, the stereochemistry at C-5′ of 14 must be inverted.
Although NvfD is predicted to be an α/β hydrolase, an example
exists in which an α/β hydrolase also possesses an epimerase
activity21. NvfD could therefore be the epimerase that converts 14
to its C-5′ epimer, which then undergoes spontaneous or NvfD-
catalyzed lactonization to yield 20. The following step utilizes the
ketoreductase, NvfG, to produce 15. Finally, NvfE and NvfF,
which are both predicted to be Fe(II)/αKG-dependent dioxy-
genases, would convert 15 into the end product, novofumigatonin
(1). We sought to obtain the predicted NvfD product 20 by
heterologously expressing the ten genes according to the
predicted pathway (Fig. 2e, lane iii), but unfortunately failed to
isolate any nvfD-speciﬁc metabolites from the transformant,
probably due to the instability of the compound. Similarly, our
attempt to isolate the genuine product from the NvfE-catalyzed
reaction was not successful, as the further addition of nvfE and
nvfG to the above constructed transformant only generated 18,
which seems to be a shunt product, as an nvfE-speciﬁc metabolite
(Fig. 2e, lane v). Nevertheless, the heterologous expression
systems with 13 genes including nvfF produced 1 (Fig. 2e, lane
vi and Fig. 2f), strongly indicating that the nvf cluster contains all
of the genes required for the novofumigatonin synthesis.
Characterization of NvfI as an endoperoxidase. The gene-
deletion experiments indicated involvement of endoperoxy pre-
cursors for orthoester generation, but the endoperoxidation
mechanism remained to be clariﬁed. To obtain deeper insight
into the endoperoxide synthesis, the predicted Fe(II)/αKG-
dependent dioxygenase NvfI was puriﬁed as a His6-tagged protein
for in vitro enzymatic reactions (Supplementary Fig. 10).
Based on the predicted function, the recombinant NvfI protein
was reacted with asnovolin A (2) under conditions similar to
those used for other αKG-dependent enzymes in our previous
studies16,22. Interestingly, the reaction did not provide the
expected product 14, but yielded its isomer 21 (Fig. 4a, lane iv).
Compound 21 was isolated from a large-scale enzymatic reaction
and determined to possess a hemiacetal linkage between C-13 and
C-2′, instead of the endoperoxide of 14, which seems to be
derived from a rearrangement of the endoperoxide by the iron
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added to the reaction mixture (Fig. 4d). Therefore, we performed
the reaction in the absence of exogenous iron, in which iron ions
copuriﬁed with NvfI can be used for the catalysis. As a result, the
reaction successfully generated 14 as the major product (Fig. 4a,
lane v), demonstrating that NvfI is solely responsible for the
endoperoxidation reaction. The reaction also yielded the mono-
hydroxylated asnovolin B6 (22) as a minor product, which was
also detected from A. oryzae transformants harboring nvfI
(Figs. 2e, 4d). Furthermore, metal- and αKG-dependences of
NvfI were conﬁrmed by observations that the reaction was
abolished in the presence of EDTA or in the absence of αKG
(Fig. 4a, lanes ii and iii).
As an αKG-dependent enzyme, the catalysis by NvfI should
follow the common mechanism seen in this class of oxidative
enzymes23: an Fe(IV)-oxo species is generated by the oxidative
decarboxylation of αKG to abstract a hydrogen atom from 2 to
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initiate the reaction. Thus, the mechanism for the endoperoxida-
tion by NvfI is proposed as follows (Fig. 4e): the hydrogen atom
at C-13 is abstracted to give the radical species 23; a molecular
oxygen is then incorporated to generate the peroxy radical 24,
which undergoes C-O bond formation at C-2′ to yield 25; and an
oxygen rebound at C-3′ completes the reaction to provide 14.
This proposed mechanism for the endoperoxidation is similar to that
proposed for the fumitremorgin B endoperoxidase (FtmOx1)24,25,
which is another αKG-dependent enzyme. However, the mechan-
isms for the radical quenching differ in these two enzymes; FtmOx1
requires a reducing agent as a hydrogen donor at the end of the
reaction, while NvfI completes the reaction by the oxygen
rebound, altogether introducing three oxygen atoms to the
substrate. For the formation of the minor product 22, the
hydrogen abstraction would occur on the C-7′ methyl group,
which is immediately followed by the rebound of the hydroxyl
radical (Fig. 4d).
Mechanistic investigation of the orthoesteriﬁcation. To unveil
how the endoperoxy precursors are transformed into novofumi-
gatonin (1) with its unique orthoester moiety, two other putative
Fe(II)/αKG-dependent dioxygenases, NvfE and NvfF, were also
puriﬁed as His6-tagged proteins (Supplementary Fig. 10). Initially,
the reaction by NvfE was investigated using similar reaction
conditions to those for NvfI. The reaction with 15 as a substrate
gave two isomeric products (Fig. 4b, lane v), one of which was
identiﬁed as 18 obtained from the A. novofumigatus nvfFΔ strain.
The other product 26 was isolated from a large-scale reaction for
the structural characterization, and quite surprisingly, it was
elucidated that 26 has a different orthoester moiety from those
seen in 1 and 18 (Figs. 2a, 4f), in which the hydroxyl group at C-
5′ is not involved in the orthoester formation. We also found that
26 is easily transformed into 18 when formic acid was added after
the completion of the reaction (Fig. 4b, lane vi). Thus, we rea-
soned that 18 is not an enzymatic product, and that 26 undergoes
an acid-catalyzed rearrangement to yield 18 (Supplementary
Fig. 11).
To evaluate the intermediacies of 18 and 26 in the
novofumigatonin pathway, these compounds were individually
incubated with NvfF, which seems to be responsible for the very
last steps of the biosynthesis. As a result, 26 was efﬁciently
converted to 1 in a metal- and αKG-dependent manner (Fig. 4c,
lanes iii to vi), but 18 was not utilized as a substrate of NvfF
(Fig. 4c, lanes i and ii), indicating that 26 is the genuine product
and substrate of NvfE and NvfF, respectively, and that 18 is a
shunt pathway product. Collectively, NvfF catalyzes two rounds
of oxidation to transform 26 into the end product, novofumiga-
tonin (1).
Despite the sequence similarity between NvfE and the known
Fe(II)/αKG-dependent dioxygenases, the reaction catalyzed by
NvfE is not an oxidation, but an isomerization event, which led us
to further investigate this intriguing enzyme. Surprisingly, the
reaction was not inhibited in the absence of αKG or in the
presence of 20 mM EDTA, and only the puriﬁed enzyme and
substrate were required for the complete reaction (Fig. 4b, lanes ii
to iv). This observation suggested that NvfE is a cofactor/
cosubstrate-free enzyme. We thus carefully analyzed the sequence
alignment between NvfE and other αKG-dependent enzymes
involved in fungal secondary metabolism (Supplementary Fig. 12).
As a result, we found that one highly conserved glutamine residue
important for the αKG binding24,26–28 is substituted with
glutamate (E149) in NvfE, while all of the residues consisting of
the iron-binding facial triad29 (H152, D154, and H234) are still
conserved. To reveal the importance of these residues, four genes
containing each of the following codon changes, E149Q, H152A,
D154A, and H234A, were constructed and the resulting mutant
enzymes were subjected to in vitro enzymatic reactions. When
incubated only with substrate 15, each of the mutant enzymes
exhibited reduced activity but did not completely lose activity
(Supplementary Fig. 13). Quite interestingly, the reactions by all
four of the mutants were enhanced in the presence of Fe2+ and/or
ascorbate and inhibited in the presence of EDTA (Supplementary
Fig. 13). Altogether, these results show that the orthoester
formation proceeds in a metal-dependent manner. The differ-
ences between the reactions catalyzed by wild-type NvfE and the
mutants could be attributed to the fact that E149 participates in
the iron binding in the active site via its carboxyl group together
with the other three residues, resulting in stronger iron-binding
afﬁnity. However, this hypothesis should be conﬁrmed by a future
X-ray crystallographic study on NvfE complexed with iron.
It is well known that Fe(II) causes the cleavage and
rearrangement of endoperoxide linkages in a variety of
compounds, such as the antimalarial agent artemisinin30. Thus,
we reasoned that the NvfE-catalyzed orthoesteriﬁcation is also
initiated by the iron-mediated cleavage of the endoperoxide and
proposed the following reaction mechanism (Fig. 4f). First, the
ferrous iron in the active site would bind to the oxygen atom at C-
13, to cleave the endoperoxide. The oxygen-centered radical 27
generated herein then undergoes β-scission to give the carbon-
centered radical 28, which is oxidized by Fe(III) to form the
carbocationic species 29. Finally, the carbocation is quenched by
the two rounds of heterocyclization, to afford the orthoester 26.
The details of the reactions catalyzed by NvfF to ﬁnalize the
biosynthesis are still not very clear, as we were not able to obtain
the product from the ﬁrst-round reaction. Nevertheless, it is
evident that NvfF is engaged in two sequential oxidative
reactions, the dehydrogenation to introduce the C-C double
bond between C-1 and C-2 and the aldehyde formation at C-13.
Homologs of NvfF are often found in the DMOA-derived
meroterpenoid pathways, and most of them catalyze multistep
reactions as NvfF16,22,31,32. Interestingly, contrary to the
commonly seen desaturation event, the aldehyde forming
reaction by NvfF is relatively rare for reactions catalyzed by
αKG-dependent enzymes. Based on the reaction mechanism
proposed for aldehyde formation by this class of dioxy-
genases33,34, the mechanism for the NvfF-catalyzed reaction to
yield the aldehyde with the rearranged orthoester could be
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proposed as follows (Fig. 4g). Initially, the ferryl-oxo species
generated in the active site of the enzyme abstracts a hydrogen
atom from C-13 of 26, or its dehydrogenated form 30, and then
hydroxylates this position, which would be the only role of NvfF
in this transformation. The resultant hemiacetal 31 is sponta-
neously converted to an aldehyde, by which a hemiorthoester
group is generated as well. The resulting hemiorthoester 32 would
then be transformed to the orthoester via the cationic
intermediate 33 by the participation of the hydroxyl group at
C-5′, thus completing the reaction. These proposed mechanisms
also explain the formation of 19 in the absence of the
ketoreductase gene nvfG (Supplementary Fig. 11). In this case,
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20, the 4′-keto analog of 15, would be accepted by NvfE and NvfF
to undergo similar rearrangement and oxidation reactions as
shown in Fig. 4f, g but a water molecule is used for the
neutralization at the last step of the reaction to give the orthoester
of 19.
Discussion
In this study, we elucidated the biosynthetic pathway of novo-
fumigatonin (1) by CRISPR-Cas9-guided gene-deletion experi-
ments, heterologous fungal expression, and in vitro enzymatic
reactions. We believe that we have demonstrated the power-
fulness of combining these three different approaches to efﬁ-
ciently elucidate a fungal natural product pathway and to identify
key enzymes for the biosynthesis.
We have identiﬁed and characterized the endoperoxidase NvfI
and the endoperoxide isomerase NvfE for the orthoester synth-
esis. The reactions catalyzed by NvfI and NvfE somewhat
resemble those by prostaglandin endoperoxide H synthases
(PGHSs) and prostacyclin or thromboxane A synthases, respec-
tively35, but differ in that these enzymes involved in prostanoid
biogenesis are heme proteins, while NvfI and NvfE utilize non-
heme iron to perform a similar set of reactions. Enzymatic
endoperoxidation has been well studied in PGHSs35, but except
for the PGHSs, fumitremorgin B endoperoxidase24 is the only
known enzyme that synthesizes an endoperoxide as a product,
despite the wide occurrence of peroxy natural products36. Inter-
estingly, NvfI shares little amino acid sequence similarity with the
known endoperoxidases, and NvfI thus represents a rare example
of an endoperoxide-producing enzyme.
It is remarkable that the orthoester synthesis is achieved by a
non-heme iron-dependent isomerase, NvfE. Non-heme iron-uti-
lizing enzymes are widespread in nature and perform versatile
reactions37, but are mostly involved in oxidative reactions.
Enzymatic orthoesteriﬁcation can be performed by the non-heme
iron-dependent enzymes for the orthosomycins pathways as
well4, but their orthoester synthesis is an oxidative reaction
without any structural rearrangement, thus completely differing
from the NvfE-catalyzed reaction. Nevertheless, there are some
examples in which isomerization reactions are catalyzed by NvfE
homologs, such as CarC38, SnoN39, and AndA16, in the carba-
penem, nogalamycin, and anditomin pathways, respectively. The
reactions by these enzymes, however, are all αKG-dependent, and
they retain their functions as oxidative enzymes as well. In con-
trast, NvfE appears to have completely lost the dioxygenase
activity, and to the best of our knowledge, NvfE is the ﬁrst
reported enzyme that gained the isomerase activity by losing the
αKG-binding ability.
Other intriguing ﬁndings regarding the NvfE-catalyzed reac-
tion are that the resultant orthoester is different from that of 1
and that the NvfE product 26 completely possesses the same
backbone structure as that of another orthoester-containing
natural product, fumigatonin40 (Fig. 5). We previously speculated
that the two different orthoesters in 1 and fumigatonin are
respectively biosynthesized in somewhat different manners7, but
our present study revealed that the novofumigatonin-type
orthoester actually originates from the fumigatonin-type orthoe-
ster. Overall, 26 would be the common precursor for the bio-
syntheses of both 1 and fumigatonin, and the biosynthetic gene
cluster for fumigatonin should contain a few more genes as
compared with those of the nvf cluster, to allow for the C-6
hydroxylation and the two acetylations (Fig. 5).
In conclusion, we have revealed the complex biosynthetic route
to novofumigatonin (1) and discovered the intriguing endoper-
oxide isomerase, NvfE, for the orthoester formation, which was
accomplished by establishing genetic engineering in A. novofu-
migatus. Further biochemical and biophysical characterizations of
NvfE will clarify this unusual chemistry and could even provide
opportunities to engineer known αKG-dependent enzymes into
αKG-independent biocatalysts to expand nature’s catalytic
versatility.
Methods
General. Solvents and chemicals were purchased from Sigma-Aldrich, VWR
International, Fisher Scientiﬁc International, Inc., Wako Chemicals Ltd., or Kanto
Chemical Co., Inc., unless noted otherwise. Oligonucleotide primers (Supple-
mentary Data 1) were purchased from Integrated DNA Technologies Inc., Euroﬁns
Genetics, or Sigma-Aldrich. PCR was performed using a T100™ Thermal Cycler
(BIO-RAD) or a TaKaRa PCR Thermal Cycler Dice® Gradient (TaKaRa), with
PfuX7 DNA polymerase41, iProof DNA polymerase (BIO-RAD), or Phire Plant
Direct PCR Master Mix (Thermo Scientiﬁc). Sequence analyses were performed by
Euroﬁns Genetics. Flash chromatography was performed using an Isolera ﬂash
puriﬁcation system (Biotage). Preparative HPLC was performed using a Waters
600 controller with a 996 photodiode array detector (Waters) or a Shimadzu
Prominence LC-20AD system. NMR spectra were obtained with Bruker AVANCE
400MHz, 600MHz, or 800MHz spectrometers at DTU NMR Center • DTU, or
JEOL ECX-500 or ECZ-500 spectrometers, and chemical shifts were recorded with
reference to solvent signals (1H NMR: CDCl3 7.26 ppm, CD3OD 3.34 ppm,
DMSO-d6 2.49 ppm, acetone-d6 2.05 ppm; 13C NMR: CDCl3 77 ppm, CD3OD 49
ppm, DMSO-d6 39.5 ppm, acetone-d6 29.9 ppm). LC–MS samples from the gene-
deletion experiments were injected into a Dionex Ultimate 3000 UHPLC system
(Thermo Scientiﬁc)—a maXis 3G QTOF orthogonal mass spectrometer (Bruker
Daltonics), using electrospray ionization with a Kinetex C18 column (2.1 i.d. × 100
mm; Phenomenex). LC–MS samples from the heterologous expression and in vitro
experiments were injected into a Shimadzu Prominence LC-20AD system with a
compact mass spectrometer (Bruker Daltonics), using electrospray ionization with
a COSMOSIL 2.5C18-MS-II column (2 i.d. × 75 mm; Nacalai Tesque, Inc.).
Strains. Aspergillus novofumigatus IBT 16806 (IFM 55215) was obtained from the
IBT Culture Collection at the Department of Biotechnology and Biomedicine,
Technical University of Denmark, Denmark, and from the Medical Mycology
Research Center, Chiba University, Japan. Aspergillus oryzae NSAR1 (niaD−, sC−,
ΔargB, adeA−)17 was used as the host for fungal heterologous expression. Standard
DNA engineering experiments were performed using Escherichia coli DH5α. E. coli
RosettaTM2(DE3)pLysS (Novagen) was used for the expression of the NvfI, NvfE,
NvfF, and NvfE mutants.
Construction of plasmids for fungal transformations. For the construction of
plasmids for the CRISPR-Cas9 system, two fragments for the expression cassette of
the targeted gene-speciﬁc single guide RNA (sgRNA) were ampliﬁed by PCR with
pFC334 as the template, and ligated into the pFC332 vector10, which had been
digested with PacI and subsequently treated with Nt.BbvCI, by the Uracil-Speciﬁc
Excision Reagent (USER) fusion method42. For the construction of plasmids for
gene-deletion experiments, approximately 1-kb of the 5′ and 3′ ﬂanking regions of
the targeted gene were ampliﬁed by PCR from the genomic DNA of A. novofu-
migatus IBT 16806, and introduced into the PacI/Nt.BbvCI USER cassette sites of
pU2002c10. The plasmids constructed in this study and the primers used for the
construction of each plasmid are listed in Supplementary Data 2.
For the construction of fungal expression plasmids for A. oryzae, each gene in
the nvf cluster, except for nvfK and nvfI, was ampliﬁed from A. novofumigatus IBT
16806 genomic DNA using the published genome sequence8, with the primers
listed in Supplementary Data 1 and 2, and initially ligated into the pTAex3
vector43, while nvfK and nvfI were introduced into the pUSA44 and pUNA45
vectors, respectively, using an In-Fusion® HD Cloning Kit (TaKaRa Clontech). To
construct multigene-containing vectors, fragments containing the amyB promoter
(PamyB) and the amyB terminator (TamyB) were ampliﬁed from the pTAex3-
based plasmids, and ligated into the previously constructed single gene-containing
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vectors or other vectors, pAdeA46, pPTRI47, or pBARI16. The plasmids constructed
in this study and the primers used for the construction of each plasmid are listed in
Supplementary Data 2.
Transformation of A. novofumigatus and A. oryzae. To transform A. novofu-
migatus IBT 16806 and its mutants, they were ﬁrst cultivated in 100 mL of mini-
mum media (6 g L−1 NaNO3, 0.52 g L−1 KCl, 0.52 g L−1 MgSO4·7H2O, 1.52 g L−1
KH2PO4, 10 g L−1 D-glucose, 10 mg L−1 thiamine, supplemented with 1 mL L−1 of
a trace element solution48) containing 1.12 g L−1 uracil and 2.44 g L−1 uridine, if
necessary, for one to two days at 30 °C and at 160 rpm. Mycelia were then collected
and incubated in TF solution 1 (40 mgmL−1 Glucanex enzymes (Novozymes A/S),
0.6 M (NH4)2SO4, 50 mM maleic acid, pH 5.5) for 3 h at 30 °C and at 160 rpm. The
resultant protoplast-containing mixture was ﬁltrated, and the ﬁltrate was washed
by TF solution 2 (10 mM Tris-HCl, pH 7.5, 1.2 M sorbitol, 50 mM CaCl2, 35 mM
NaCl). The protoplast was resuspended in TF solution 2 to a concentration of
1–5 × 107 cells mL−1 and mixed with the transformation plasmid(s), which was
further incubated for 30 min at room temperature. A total of 1.35 mL of TF
solution 3 (10 mM Tris-HCl, pH 7.5, 60 % PEG4000, 50 mM CaCl2) was then
added in three portions to the mixture of the protoplast and plasmids. After 20 min
incubation at room temperature, the mixture was diluted with 5 mL of TF solution
2 and 6 mL of the molten transformation agar media (6 g L−1 NaNO3, 0.52 g L−1
KCl, 0.52 g L−1 MgSO4·7H2O, 1.52 g L−1 KH2PO4, 10 g L−1 D-glucose, 188.2 g L−1
sorbitol, 10 mg L−1 thiamine, and 20 g L−1 agar supplemented with 1 mL L−1 of a
trace element solution48), which was poured on the top of the pre-made trans-
formation agar media plate. The plate was further incubated for about a week at 25
°C until mutant colonies appear.
For the deactivation of the pyrG gene (Protein ID in JGI database: 399623),
pFC332-Aspnov_pyrG was used for transformation of A. novofumigatus IBT
16806. Transformants were selected on transformation media supplemented with
1.12 g L−1 uracil, 2.44 g L−1 uridine, and 100 mg L−1 hygromycin B. Mutant strains
with the pyrG– genotype were selected on minimum agar media (6 g L−1 NaNO3,
0.52 g L−1 KCl, 0.52 g L−1 MgSO4·7H2O, 1.52 g L−1 KH2PO4, 10 g L−1 D-glucose,
10 mg L−1 thiamine, 20 g L−1 agar, supplemented with 1 mL L−1 of a trace element
solution48), containing 1.30 g L−1 of 5-ﬂuoroorotic acid (5-FOA) to obtain
transformants in which the pyrG gene is deactivated, since the wild-type strain is
sensitive to 5-FOA. The selected pyrG− strain was then transformed to delete the
ligD gene (Protein ID in JGI database: 439258), using both pFC332-Aspnov_ligD
and pU2002c-Aspnov_ligD, and the transformant was selected on transformation
media supplemented with hygromycin B. Transformants were then cultivated on
minimal media supplemented with uracil and uridine, to induce the elimination of
the pyrG marker gene (AfpyrG: pyrG from Aspergillus ﬂavus) via intramolecular
homologous recombination (Supplementary Fig. 3), and were further selected with
5-FOA, hereby creating the pyrG−, ligDΔ strain.
The pyrG–, ligDΔ strain was transformed with the pU2002c-based plasmids
corresponding to the targeted gene(s) (Supplementary Data 2), and transformants
were selected on minimal media. When deleting nvfK, nvfM, and nvfD-G, pFC332-
based plasmids (Supplementary Data 2) were used as well, since transformations
with only pU2002c-based plasmids were inefﬁcient. To construct the strain lacking
the nvfD-G and e-anaPS genes, the AfpyrG gene was eliminated from the pyrG–,
ligDΔ, nvfD-GΔ::AfpyrG strain, and the resulting mutant was transformed with
pFC332-e-anaPS and pU2002c-e-anaPS. The successful deletion of targeted genes
was conﬁrmed by colony-direct PCR of each transformant (Supplementary Fig. 4).
The mutant strains of A. novofumigatus constructed in this study were deposited in
the IBT Culture Collection at the Department of Biotechnology and Biomedicine,
Technical University of Denmark (Supplementary Table 3).
To transform A. oryzae NSAR1 and its mutants, they were ﬁrst cultivated in
DPY medium (2% dextrin, 1% hipolypepton (Nihon Pharmaceutical Co., Ltd.),
0.5% yeast extract (Difco), 0.5% KH2PO4, and 0.05% MgSO4·7H2O) for one to two
days at 30 °C and at 160 rpm. The general transformation procedure is the same as
described for A. novofumigatus except that Yatalase (TaKaRa) was used as fungal
cell lytic enzymes at a concentration of 10 mgmL−1. Transformants were selected
on M-sorbitol media (0.2% NH4Cl, 0.1% (NH4)2SO4, 0.05% KCl, 0.05% NaCl, 0.1%
KH2PO4, 0.05% MgSO4·7H2O, 0.002% FeSO4·7H2O, 2% glucose, and 1.2 M
sorbitol, pH 5.5) or CD-sorbitol media (0.3% NaNO3, 0.2% KCl, 0.1% KH2PO4,
0.05% MgSO4·7H2O, 0.002% FeSO4·7H2O, 2% glucose, and 1.2 M sorbitol, pH 5.5)
supplemented with 0.1% arginine, 0.15% methionine, 0.01% adenine, 0.1 µg mL−1
pyrithiamine hydrobromide, and/or 50 µLmL−1 glufosinate solution16 depending
on the selection markers used in the transformation. The plates were further
incubated for about a week at 30 °C until mutant colonies appear. Transformants of
A. oryzae constructed in this study and plasmids used for each transformation are
listed in Supplementary Table 4.
LC–MS analyses. Aspergillus novofumigatus IBT 16806 and its mutants were
cultivated on YES agar plates (20 g L−1 yeast extract, 150 g L−1 sucrose, 0.5 g L−1
MgSO4·7H2O, 20 g L−1 agar supplemented with 1 mL L−1 of a trace element
solution, pH 6.5) at 25 °C for seven days, whereafter metabolites were extracted
with ethyl acetate using ultrasonication. Separation was performed with a solvent
system of water containing 20 mM formic acid (solvent A) and acetonitrile con-
taining 20 mM formic acid (solvent B), at a ﬂow rate of 0.4 mLmin−1 and a
column temperature of 40 °C, using the following program: a linear gradient from
10:90 (solvent B/solvent A) to 100:0 for 10 min, 100:0 for the following 3 min, and a
linear gradient from 100:0 to 10:90 within the following 2 min.
Transformants of A. oryzae were grown in shaking cultures in DPY medium for
three days at 30 °C and at 160 rpm, and the culture broth was extracted with ethyl
acetate. Separation was performed with a solvent system of water containing 20
mM formic acid (solvent A) and acetonitrile containing 20 mM formic acid
(solvent B), at a ﬂow rate of 0.1 mL/min and a column temperature of 40 °C, using
the following program: 50:50 (solvent B/solvent A) for 3 min, a linear gradient
from 50:50 to 100:0 within the following 17 min, 100:0 for 3 additional min, and a
linear gradient from 100:0 to 50:50 within the following 1 min.
Analytical conditions for products from in vitro enzymatic reactions were the
same as those described for metabolites from A. oryzae transformants.
Isolation and puriﬁcation of each metabolite. For the isolation of each meta-
bolite from A. novofumigatus, wild type and mutants were inoculated on 100 to 200
YES agar plates (ca. 2–4 L), respectively, and cultivated for ~10 days at 25 °C. The
resulting fungal cultures were extracted with ethyl acetate twice, fractionated by
ﬂash chromatography, and puriﬁed by preparative HPLC. For the isolation of each
metabolite from A. oryzae transformants, media from 1 to 4 L of the culture were
extracted with ethyl acetate. Mycelia were extracted with acetone at room tem-
perature, concentrated, and reextracted with ethyl acetate. Both extracts were
combined and subjected to open column chromatography and further puriﬁcation
by preparative HPLC. The detailed puriﬁcation procedures and structural char-
acterizations of the compounds are described in Supplementary Notes 1 to 18, and
the spectral data are provided in Supplementary Figs. 14 to 100 and Supplementary
Tables 5 to 22.
Hydrogenolysis of fumigatonoid B (15). To a stirred solution of 15 (4.4 mg, 9
μmol) in isopropanol (14 mL) was added 10% palladium on activated charcoal (~5
mg), and the mixture was stirred for 5 h under a hydrogen atmosphere. The
suspension was then ﬁltered through a PTFE syringe ﬁlter (0.45 µm), and the
solvent was removed in vacuo. The crude product was puriﬁed by reverse-phase
preparative HPLC (40% aqueous acetonitrile, 5 mLmin−1) on a Luna II C18
column (250 × 10 mm, 5 μm, Phenomenex), to yield 3.6 mg (82%, 7.5 μmol) of a
white amorphous solid. HR-ESI-MS found m/z 489.2463 [M+Na]+ (calcd.
489.2459 for C25H38O8Na).
Expression and puriﬁcation of the Nvf enzymes. To express nvfI, nvfE, and nvfF
in E. coli, complementary DNA (cDNA) for each gene was introduced into the
pET-28a(+) vector (Novagen), using an In-Fusion® HD Cloning Kit (Supple-
mentary Data 2). To obtain an intron-free nvfI gene, total RNA was extracted from
an A. oryzae transformant expressing nvfI using ISOGEN (Nippon Gene Co., Ltd.),
and cDNA was synthesized with SuperScript™ III Reverse Transcriptase (Invitro-
gen) from the extracted RNA. The intron-free nvfE gene was generated by
amplifying and ligating the two predicted exons. The nvfF gene has no intron, and
therefore it was directly ampliﬁed from A. novofumigatus genomic DNA. NvfE
mutants were constructed by PCR methods, using pairs of the mutation primers.
For the expression of NvfI, NvfE, NvfF, and NvfE mutants, E. coli RosettaTM2
(DE3)pLysS was transformed with the pET-28a(+ )-based plasmid for each gene.
The transformants were incubated with shaking at 37 °C/160 rpm, in ZYM-G
medium49 supplemented with 50 mg L−1 kanamycin sulfate and 12.5 mg L−1
chloramphenicol. When the cultures had grown to an OD600 of 0.6, gene
expression was induced by the addition of 0.5 mM IPTG. Then, the incubation was
continued for 14 h at 30 °C/160 rpm. The cells were harvested by centrifugation
and resuspended in lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM
imidazole, 5% glycerol). After lysis on ice by sonication, the cell debris was
removed by centrifugation. The supernatant was loaded onto a Ni-NTA afﬁnity
column. Unbound proteins were removed with 30 column volumes of wash buffer
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10 mM imidazole, 5% glycerol). His-
tagged proteins were eluted with 5 column volumes of elution buffer (50 mM Tris-
HCl, pH 7.5, 150 mM NaCl, 300 mM imidazole, 5% glycerol). The purity of the
enzymes was analyzed by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) (Supplementary Fig. 10). The protein concentrations
were determined using a SimpliNano Spectrophotometer (GE Healthcare Life
Sciences).
Enzymatic reaction assay of puriﬁed proteins. All of the enzymatic reactions
were performed in 50 μL reaction mixtures at 30 °C, and terminated by adding 50
μL of methanol and vortex mixing, and then the supernatant obtained after cen-
trifugation was analyzed by LC–MS.
The standard enzymatic reaction of NvfI with asnovolin A (2) was performed in
reaction mixtures containing 50 mM Tris-HCl buffer (pH 7.5), 250 μM of 2, 2.5
mM α-ketoglutarate, 4 mM ascorbate, and 9.6 μM NvfI, for 2.5 h. When necessary,
0.1 mM FeSO4 or 1 mM EDTA was added to the reaction.
The standard enzymatic reaction of NvfE with fumigatonoid B (15) was
performed in reaction mixtures containing 50 mM Tris-HCl buffer (pH 7.5), 50 μM
of 15, 2.5 mM α-ketoglutarate, 4 mM ascorbate, and 20.7 μM NvfE, for 2.5 h. When
required, 20 mM EDTA was added to the reaction. To investigate the stability of
26, formic acid (ﬁnal conc. 0.5%) was added after the completion of the reaction.
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The standard enzymatic reaction of NvfF with asnovolin G (18) or
fumigatonoid C (26) was performed in reaction mixtures containing 50 mM Tris-
HCl buffer (pH 7.5), 50 μM of 18 or 26, 2.5 mM α-ketoglutarate, 4 mM ascorbate,
and 11.1 μM NvfF, for 1 h. When required, 1 mM EDTA was added to the reaction.
The standard enzymatic reaction of NvfE or its mutants with fumigatonoid B
(15) was performed in reaction mixtures containing 50 mM Tris-HCl buffer (pH
7.5), 50 μM of 15, and 4 μM NvfE or its mutants, for 1.5 h. When required, 0.1 mM
FeSO4, 4 mM ascorbate, or 1 mM EDTA was added to the reaction.
Data availability. The authors declare that the data supporting the ﬁndings of this
study are available within the article and its Supplementary Information and from
the corresponding authors upon reasonable request.
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